30 closest matches · ranked by relevance
Congestive Heart Failure
Primary: Change in Natriuresis (Urinary Sodium Excretion) in Control Subjects at 60 Minutes After Volume Expansion Compared to Baseline in Response to Placebo Treatment — 87.19…
Surgery
Primary: Occurence of Adverse Cardiac Events — 91 participants
Fluid Overload · Fluid Loss · Volume Overload
Primary: Number of Patients With Pro-ANP Twofold Raise by the End of Surgery — 17 Participants
Left Ventricular Diastolic Dysfunction
Primary: Change in Urinary Sodium Excretion in Response to Saline Load — 381.6; -10.5 mEq/minute — p=<0.001
Serum CNP Levels · Healthy Reproductive Age Women · Healthy Perimenopausal Women
Primary: Serum C Type Natriuretic Peptide Levels — 43.68; 55.98; 116.36 pg/ml — p=<0.017
Healthy · Lean
Primary: Changes in NT-proANP From Baseline to 8 Hours — -0.33 nmol/l
Heart Failure · Asymptomatic Systolic Dysfunction
Primary: Change in Urinary Sodium Excretion in Response to Saline Load — 179.1; 3.1 mEq/min — p=<0.05
Congestive Heart Failure · Cardiomyopathy
Primary: Change in Left Ventricular (LV) Volume Index at 8 Weeks — -5.2; 5.8; -10.0; 6.1 ml/m^2 — p=0.004
Natriuretic Peptides · Obesity · Nocturnal Blood Pressure
Primary: Plasma MRproANP — 17.92; 15.51 pmol/l — p=0.003
Chronic Heart Failure
Primary: Natriuretic Brain Pro-peptid — 312; 200 pg/ml
Healthy · Pre Hypertension
Primary: Change in Plasma BNP After 6-weeks of Beta-Blocker — 45; 74 Percentage Change in Plasma BNP levels
Acute Myocardial Infarction
Primary: Change in Left Ventricular End-Systolic Volume Index — -2.1; -4.6 mL of blood/meter^2 body surface area — p=0.97
Fluid Over-load
Primary: Length of Stay — 4; 6 days
Heart Decompensation
Primary: Composite of Rehospitalization Due to Heart Failure and All-Cause Mortality — 321; 345 Participants — p=0.313
Renal Failure
Primary: Measure Neutrophils to Measure Kidney Injury — 5.453; 5.630; 4.508; 4.546 log2 expression
Heart Failure With Preserved Ejection Fraction
Primary: Change in Plasma N-terminal Proatrial Natriuretic Peptide (NT proANP) — 47.4; 46.4 pg/mL
Polycystic Ovary Syndrome · c Type Natriuretic Peptide · Menstrual Irregularity
Primary: Serum CNP Levels of PCOS and Healthy Participants — 110; 57 pg/ml — p=0.004
Healthy · Natriuretic Peptides · Metabolic Syndrome
Primary: Plasma MRproANP — 23 Percentage of change
Acute Decompensated Heart Failure
Primary: Renal Function by Serum Creatinine — 1.3; 1.3; 1.3; 1.4 mg/dL
Obesity
Primary: Adipose Tissue Gene Expression of UCP1 (Uncoupling Protein 1)- Differences by Obesity Status — 7.79; 24.33 fold change — p=<0.01
Heart Failure Acute
Primary: Total Natriuresis After 24 Hours — 409; 345 mmol
Chronic Heart Failure (CHF)
Primary: Number of Clinically Stable Patients Whose Therapy Regimen Adheres to ESC Guideline Recommendations for Drug Types (Level 1) and Drug Type and Dose (Level 2) at Visit 1…
Breast Cancer
Primary: Pre-operative Concentration of NT-proBNP — 38.9; 32.2 pg/ml — p=0.714
Congestive Heart Failure
Primary: Change in Natriuresis (Urinary Sodium Excretion) at 60 Minutes for Preclinical Systolic Dysfunction (PSD) Reporting Group — 41.8; 88.9 mEq/min — p=0.26
Congenital Heart Disease · Cardiovascular Disease
Primary: BNP Levels — 16.3; 42.4; 384.3 pg/ml
Heart Disease · Heart Failure With Preserved Ejection Fraction · Exercise Intolerance
Primary: Exercise Pulmonary Capillary Wedge Pressure (PCWP) — 19.0; 28.0 mm Hg — p=0.0003
Heart Failure
Primary: Cardiorespiratory Fitness — 4.1; 4.0; 5.1; 4.5 ml/kg/min
Mood Disorder · Anxiety Disorders
Primary: Levels of NPY in CSF — 329.4; 351.0 pg/mL
Heart Failure
Primary: Skeletal Muscle Bioenergetics- Polymerase Chain Reaction (PCR) — 12.04; 11.91; 11.79; 11.76 Relative Expression
Heart Failure
Primary: Change in Pulmonary Capillary Wedge Pressure During Exercise — -1; -4 millimeters of mercury — p=0.002